US Stock MarketDetailed Quotes

Kyverna Therapeutics (KYTX)

Watchlist
  • 8.540
  • -0.950-10.01%
Close May 18 15:59 ET
  • 8.720
  • +0.180+2.10%
Post 18:36 ET
519.19MMarket Cap-2.61P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics (KYTX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2022/FY
Stock NameRevenueRatio
Developing therapies for autoimmune and inflammatory diseases7.03M100.00%

By Country/Region

Currency:USD
2022/FY
Stock NameRevenueRatio
United States7.03M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +28.67%
Sample Name
Sample Code
 +23.05%
Sample Name
Sample Code
 +22.42%
4
United Sts Brent Oil Fd Lp Unit
BNO
+21.50%
5
ProShares Ultra Energy
DIG
+19.88%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.81%
Sample Name
Sample Code
 +5.47%
Sample Name
Sample Code
 +3.50%
4
Hesai
HSAI
+0.96%
5
MINISO
MNSO
-0.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -